XML 14 R45.htm IDEA: XBRL DOCUMENT v3.20.1
Warrants (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Nov. 21, 2019
Nov. 04, 2019
Sep. 27, 2019
Mar. 31, 2020
Dec. 31, 2019
Pre-Merger Financing Warrants          
Percentage of excess common stock on pre-merger financing warrants exercised one (in percentage)     4.99%    
Percentage of excess common stock on pre-merger financing warrants exercised two (in percentage)     9.99%    
Percentage of amount on market value for failure to issue common stock on pre-merger financing warrants (in percentage)     2.00%    
Series A Warrants          
Pre-Merger Financing Warrants          
Initial exercise price (in USD per share)       $ 7.13  
Warrants and rights outstanding, term       60 months  
Number of common shares in to which the warrants are exercisable (in shares)       8,800,000  
Proceeds from warrant exercises, maximum amount       $ 10.0  
Series B Warrants          
Pre-Merger Financing Warrants          
Initial exercise price (in USD per share)     $ 0.01    
Number of common shares in to which the warrants are exercisable (in shares)     8,000,000.0 12,600,000  
Warrants, exercise price determination, number of trading days     10 days    
Percentage of volume-weighted average trading price of a share of common stock that triggered release of converted additional shares (in percentage)   80.00%      
Price over which trading price of common stock as quoted on the Nasdaq Capital Market was considered for the release of converted additional shares (in USD per share) $ 1.00 $ 1.00      
Number of warrants outstanding (in shares)       1,000 1,000
Series C Warrants          
Pre-Merger Financing Warrants          
Initial exercise price (in USD per share)       $ 7.13  
Number of common shares in to which the warrants are exercisable (in shares)   50,000,000.0      
Price over which trading price of common stock as quoted on the Nasdaq Capital Market was considered for the release of converted additional shares (in USD per share)   $ 1.20      
Number of warrants outstanding (in shares)       1,000 1,000
Series C Warrants | Maximum          
Pre-Merger Financing Warrants          
Number of common shares in to which the warrants are exercisable (in shares)   50,000,000.0   20,000,000.0  
Former Ocugen Warrants          
Pre-Merger Financing Warrants          
Initial exercise price (in USD per share)       $ 5.67  
Class of warrant or right, exercisable (in shares)       900,000 900,000